Advertisement · 728 × 90
#
Hashtag
#Obesity
Advertisement · 728 × 90

Hooray! More of this please. 👏 🚲 Our continued existence on the planet depends on it. #ClimateCrisis #disease #obesity #MentalHealth #happiness #CleanAir

2 0 0 0
Post image

medicalxpress.com/news/2026-04... #obesity
High‑fat diets linked to rapid decline in protective gut immune cells

2 0 0 0
Post image

Get #scholarship for learning #reproducibility, #datascience, #FAIRdata & #openscience! Apply to dkNET Summer of Data Student Program by 4/13/2026
📌 Open to undergrad. to grad. students
📌 Working in a #endocrine #diabetes #obesity or #kidney lab
Link: dknet.org/about/Summer...

0 0 0 0
JAMA "Manufacturer-Sponsored Coupon Use and Brand-Name Drug Costs Among Patients With Insurance". Graph of patient-level use of coupons by therapeutic area (2017-2025). Anticoagulants, antipsychotics, obesity drugs, immunomodulator, and diabetes trends shown.

JAMA "Manufacturer-Sponsored Coupon Use and Brand-Name Drug Costs Among Patients With Insurance". Graph of patient-level use of coupons by therapeutic area (2017-2025). Anticoagulants, antipsychotics, obesity drugs, immunomodulator, and diabetes trends shown.

Manufacturer-sponsored coupon use for brand-name drugs declined from 2017 to 2024 among US patients, but per-claim coupon amounts increased, especially for #Obesity and #Diabetes therapies.

ja.ma/4tAH4sZ

1 0 0 0
Post image

Function | Monday Insights ☕CALL FOR PAPERS! Submit your best work in the area of #obesity and #metabolic #physiology. Learn more: https://ow.ly/vtCq50YyMsE

0 0 0 0
Post image Post image Post image

Proposed BMI cut-offs (young Indian population):
• 22.09 (men)
• 23.73 (women)

↑ sensitivity vs BMI ≥25

BMI alone may not reflect true body fat.

Read more: www.cureus.com/articles/472...

#cureus #obesity #bmi #publichealth #meded #health

0 0 0 0
Post image

New #genetic #risk #score better #predicts #diabetes, #obesity dow& nstream #complications

A polygenic risk score uses multiple genetic factors to estimate if a person will develop a complex medical condition & predicts their long-term health outcomes scitechupdates.com/n...

0 0 0 0
Video

GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and #obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read the full review: nej.md/4sUFlys

#MedSky #EndoSky #T2D

6 2 0 1
JAMA viewpoint: "CMS BALANCE Model for Obesity—Implications for Patients and Clinicians" by Hamlet Gasoyan, Michael B. Rothberg, published online April 2, 2026. doi: 10.1001/jama.2026.2894.

JAMA viewpoint: "CMS BALANCE Model for Obesity—Implications for Patients and Clinicians" by Hamlet Gasoyan, Michael B. Rothberg, published online April 2, 2026. doi: 10.1001/jama.2026.2894.

💬 Viewpoint: Standardized coverage and incentives in the CMS BALANCE model may reduce prior authorization burden and financial barriers for novel #obesity medications, but broad program participation and persistence remain uncertain.

ja.ma/41aLlHp

5 1 0 0
Post image

This common body shape could quietly raise heart failure risk Researchers found that heart failure risk from belly fat may be driven by hidden inflammation, even in people with a normal BMI. Two pe...

#Health #and #Fitness #Lifestyle #Featured #heart #attack #obesity

Origin | Interest | Match

1 0 0 0
JAMA Research Letter, published April 2, 2026, titled "Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements." Table 1 shows coverage and cost sharing for semaglutide injectables under Medicare Part D, 2023-2026.

JAMA Research Letter, published April 2, 2026, titled "Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements." Table 1 shows coverage and cost sharing for semaglutide injectables under Medicare Part D, 2023-2026.

From @jama.com: At a $245/month price, the CMS BALANCE model could save Medicare nearly $933 million on #semaglutide in 2027, offsetting costs for up to 550 000 additional beneficiaries eligible for #obesity coverage.

ja.ma/4coKTLP

2 0 0 0
JAMA Research Letter, published April 2, 2026, titled "Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements." Table 1 shows coverage and cost sharing for semaglutide injectables under Medicare Part D, 2023-2026.

JAMA Research Letter, published April 2, 2026, titled "Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements." Table 1 shows coverage and cost sharing for semaglutide injectables under Medicare Part D, 2023-2026.

From @jama.com: At a $245/month price, the CMS BALANCE model could save Medicare nearly $933 million on #semaglutide in 2027, offsetting costs for up to 550 000 additional beneficiaries eligible for #obesity coverage.

ja.ma/4c88lf2

0 0 0 0
Preview
Personalized Medical Nutrition Therapy and Physical Exercise: The Future of Diabesity Care To achieve sustained metabolic control and improved quality of life, diabesity care will need to integrate personalized medical nutrition therapy and structured physical exercise with pharmacotherapy.

To achieve sustained metabolic control and improved quality of life, #diabesity care will need to integrate personalized medical nutrition therapy and structured physical exercise with pharmacotherapy.

Find out more 👉 buff.ly/Amx6R0y

#Diabetes #Obesity

1 0 0 0

Another person I know has started taking obesity drugs. Now I know two. Sure, they know that they may have to take them for a long time, if not forever. But do they know that there have been no long term trials of these drugs?

#health
#obesity
#drugs

3 0 1 0

The article says #obesity plays a role, maybe the GLP-1s will start bending that curve a bit, but I honestly think a lot of it is lack of #healthcare access for GenX, they are by far the hardest hit with ACA #healthinsurance price increases, may not be keeping up with PCP, screening, etc

1 0 0 0
Post image

This week's #featured #article explores the various determinants of #Obesity among #immigrants from #iran in #australia Click the link in the post below to read more!

#health #ethnicity #food #immigration #victoria

1 1 1 0
Post image

Our congress brings together #obesity KOLs, NCDs experts, decision-makers, patients + media.

Register for #ECO2026

eco2026.org

1 0 0 0
Preview
Pharmalittle: We're reading about Trump's drug tariffs, a U.S.-U.K. pharma trade deal, and more The Trump administration announced 100% tariffs on imported brand-name drugs, but with significant caveats

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Trump’s drug tariffs, a U.S.-U.K. pharma trade deal, and more news.. statnews.com/pharmalot/20... #pharma #biotech #Trump #tariffs #obesity #Medicare

0 0 0 0
Preview
Irisin ameliorates obesity and insulin resistance via adipose tissue IL-33 and regulatory T cells - Nature Metabolism This study demonstrates that overexpression of irisin, an exercise-induced myokine, ameliorates obesity and insulin resistance in high-fat-diet-fed mice by increasing local IL-33 production and preser...

Novel irisin-driven cell–cell and inter-tissue immune interactions improve #obesity and glucose intolerance, and increase energy expenditure, with no reduced food intake and muscle loss in obese mice. www.nature.com/articles/s42...

1 0 0 0
JAMA viewpoint article titled "CMS BALANCE Model for Obesity—Implications for Patients and Clinicians" by Hamlet Gasoyan and Michael B. Rothberg. Published online: April 2, 2026. doi: text@1

JAMA viewpoint article titled "CMS BALANCE Model for Obesity—Implications for Patients and Clinicians" by Hamlet Gasoyan and Michael B. Rothberg. Published online: April 2, 2026. doi: text@1

💬 Viewpoint: Standardized coverage and incentives in the CMS BALANCE model may reduce prior authorization burden and financial barriers for novel #obesity medications, but broad program participation and persistence remain uncertain.

ja.ma/4m5a8Ge

2 0 0 1
A research letter from JAMA, published online April 2, 2026, titled "Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements." Table 1 shows coverage and cost sharing per fill for semaglutide injectables under Medicare Part D, 2023-2026.

A research letter from JAMA, published online April 2, 2026, titled "Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements." Table 1 shows coverage and cost sharing per fill for semaglutide injectables under Medicare Part D, 2023-2026.

At a $245/month price, the CMS BALANCE model could save Medicare nearly $933 million on #semaglutide in 2027, offsetting costs for up to 550 000 additional beneficiaries eligible for #obesity coverage.

ja.ma/4dqkQoL

3 0 0 0
Post image

Prevention AND treatment must go hand in hand.

No silver bullet. Obesity is complex - and linked to 200+ conditions.

We need prevention, early intervention, and access to care - all working together.

🔗 www.worldobesity.org
#Obesity #NCDs #PublicHealth

1 0 0 0
Preview
Irisin may be involved in exendin-4 mitochondrial action in human adipocytes Introduction: Disturbed mitochondrial activity in adipocytes is suggested as one of the mechanisms involved in metabolic dysfunction in obesity. Glucagon-like peptide receptor agonists (GLP-1RAs) are...

#obesity #irisin #mitochondria #mitochondrialdysfunction #adipocyte #exendin-4 #GLP-1RA

www.archivesofmedicalscience.com/Irisin-may-b...

0 0 0 0
Preview
Obesity, sleep, smoking, and inactivity show the strongest links to hypertension in U.S. adults A national U.S. analysis shows that weight, sleep, smoking, and exercise habits may matter more for hypertension than overall diet score alone, with sodium still standing out as an important dietary factor. Study: Association Between Life’s Essential 8 Lifestyle Behaviors and Hypertension: A Cross-Sectional Analysis of NHANES Data. Image Credit: NMK-Studio / Shutterstock In a recent study published in the Journal of Cardiovascular Nursing, researchers investigated associations between five lifestyle behaviors from the Life’s Essential 8 (LE8) framework and hypertension. The cross-sectional study analyzed National Health and Nutrition Examination Survey (NHANES) data from 20,912 adults to examine the association between recommended lifestyle behaviors and hypertension. Results indicated a high prevalence of hypertension (52.7%) and identified significant independent associations between hypertension and modifiable health behaviors. Adherence to healthier LE8 behaviors was associated with lower odds of hypertension, although causality and cardiovascular outcomes were not directly assessed. Background Hypertension, commonly referred to as high blood pressure, is a chronic condition characterized by persistently elevated force of blood against arterial walls. Often described as a “silent killer” due to its lack of overt symptoms, it is strongly associated with cardiovascular disease and increased mortality risk. Although pharmacological treatments are widely used, growing evidence,...

Obesity, sleep, smoking, and inactivity show the strongest links to hypertension in U.S. adults
->News-Medical | More on "Hypertension lifestyle risk factors study" at BigEarthData.ai | #Obesity

0 0 0 0
Preview
Experts Question Evidence for New Testosterone Advice New federal dietary guidance includes advice on boosting testosterone levels, which clinicians say is only partially rooted in evidence.

“‘Testosterone health’ is a “nonsense statement"

My story for @medscape.com

#Medsky #Endosky #supplements #hormones #diet #nutrition #Foodpyramid #endocrinology #obesity #weightloss

3 2 0 0
JAMA viewpoint: "CMS BALANCE Model for Obesity—Implications for Patients and Clinicians" by Hamlet Gasoyan, Michael B. Rothberg. Published online April 2, 2026. DOI: 10.1001/jama.2026.2894.

JAMA viewpoint: "CMS BALANCE Model for Obesity—Implications for Patients and Clinicians" by Hamlet Gasoyan, Michael B. Rothberg. Published online April 2, 2026. DOI: 10.1001/jama.2026.2894.

💬 Viewpoint: Standardized coverage and incentives in the CMS BALANCE model may reduce prior authorization burden and financial barriers for novel #obesity medications, but broad program participation and persistence remain uncertain.

ja.ma/41egCZZ

1 0 0 0
A research letter from JAMA titled "Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements" includes a table showing the coverage and cost sharing per fill for semaglutide injectables under Medicare Part D from 2023-2026.

A research letter from JAMA titled "Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements" includes a table showing the coverage and cost sharing per fill for semaglutide injectables under Medicare Part D from 2023-2026.

At a $245/month price, the CMS BALANCE model could save Medicare nearly $933 million on #semaglutide in 2027, offsetting costs for up to 550 000 additional beneficiaries eligible for #obesity coverage.

ja.ma/4c7C0VL

2 0 0 0
Video

www.tumblr.com/thefattestsb...

you couldn’t handle all of this fat… could you?😳😜

#feedee belly #feedee girl
#feeding kink #curvage model
#gaining weight on purpose
#obese belly #obese piggy
#belly gainer #fat belly #fat girls
#ssbbwgoddess #ssbbw feedee
#fat piggy #sexy obese #obesity

14 2 0 0
Preview
Pharmalittle: We're reading about Trump tariff plans, FDA's OK for a Lilly obesity pill, and more The Trump administration has prepared an order to impose a 100% tariff on imports of some patented medicines and their active ingredients

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Trump tariff plans, FDA’s OK for a Lilly obesity pill, and more news.. statnews.com/pharmalot/20... #pharma #layoffs #Trump #tariffs #obesity #vaccines #FDA #Pfizer #Lilly

1 0 0 0
Post image

After pulling in $1 billion across two private rounds, Kailera heads for public markets to keep pace in one of biotech’s most expensive races.

Link as first comment.

#longevity #geroscience #obesity #biotech #ipo

0 0 1 0